Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
 Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02013492
27:39:chronic_disease,,,,
Patients with significant lung disease, an ejection fraction less than 40%, or a resting heart rate less than 60/min will not be enrolled
2
[ "Patients", "with", "significant", "lung", "disease", ",", "an", "ejection", "fraction", "less", "than", "40", "%", ",", "or", "a", "resting", "heart", "rate", "less", "than", "60/min", "will", "not", "be", "enrolled" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02336217
1:10:treatment
Treatment by Marshall Internal Medicine Department
2
[ "Treatment", "by", "Marshall", "Internal", "Medicine", "Department" ]
[ 1, 0, 0, 0, 0, 0 ]
NCT03058146
1:14:chronic_disease
heart failure
2
[ "heart", "failure" ]
[ 2, 2 ]
NCT02556606
41:50:allergy_name
Past intolerance or hypersensitivity to midazolam
2
[ "Past", "intolerance", "or", "hypersensitivity", "to", "midazolam" ]
[ 0, 0, 0, 0, 0, 4 ]
NCT02133573
,,,,110:130:treatment
History of preterm birth or short cervix (defined as cervical length ≤ 25 mm at 18-24 weeks GA necessitating progesterone therapy
2
[ "History", "of", "preterm", "birth", "or", "short", "cervix", "(", "defined", "as", "cervical", "length", "≤", "25", "mm", "at", "18-24", "weeks", "GA", "necessitating", "progesterone", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02530073
,,77:109:treatment
Preterm labor, cervix shortened (<15 mm at enrollment or within 24 hours of FETO balloon insertion procedure) or uterine anomaly strongly predisposing to preterm labor, placenta previa
2
[ "Preterm", "labor", ",", "cervix", "shortened", "(", "<", "15", "mm", "at", "enrollment", "or", "within", "24", "hours", "of", "FETO", "balloon", "insertion", "procedure", ")", "or", "uterine", "anomaly", "strongly", "predisposing", "to", "preterm", "labor", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03100435
36:57:allergy_name,67:104:chronic_disease,108:126:chronic_disease
Subjects with contraindications to wearing a mouth guard, such as chronic obstructive pulmonary disease or severe sleep apnea
2
[ "Subjects", "with", "contraindications", "to", "wearing", "a", "mouth", "guard", ",", "such", "as", "chronic", "obstructive", "pulmonary", "disease", "or", "severe", "sleep", "apnea" ]
[ 0, 0, 0, 0, 4, 4, 4, 4, 0, 0, 0, 2, 2, 2, 2, 0, 2, 2, 2 ]
NCT02581787
21:39:treatment,30:39:treatment,41:53:treatment,55:71:treatment,76:89:treatment
No prior receipt of systemic treatment (chemotherapy, targeted therapy, or immunotherapy) for the lesion under consideration of treatment
2
[ "No", "prior", "receipt", "of", "systemic", "treatment", "(", "chemotherapy", ",", "targeted", "therapy", ",", "or", "immunotherapy", ")", "for", "the", "lesion", "under", "consideration", "of", "treatment" ]
[ 0, 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01891812
15:34:chronic_disease
Patients with sickle cell disease
2
[ "Patients", "with", "sickle", "cell", "disease" ]
[ 0, 0, 2, 2, 2 ]
NCT00788164
15:51:cancer
No concurrent adenocarcinoma in situ of the cervix
2
[ "No", "concurrent", "adenocarcinoma", "in", "situ", "of", "the", "cervix" ]
[ 0, 0, 3, 3, 3, 3, 3, 3 ]
NCT02446457
17:29:treatment,
enrolled in the lenalidomide cohort must adhere to the scheduled pregnancy testing as required in the Revlimid Risk Evaluation and Mitigation Strategy (REMS) program
2
[ "enrolled", "in", "the", "lenalidomide", "cohort", "must", "adhere", "to", "the", "scheduled", "pregnancy", "testing", "as", "required", "in", "the", "Revlimid", "Risk", "Evaluation", "and", "Mitigation", "Strategy", "(", "REMS", ")", "program" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02471430
27:37:chronic_disease
No clinically significant eye disease
2
[ "No", "clinically", "significant", "eye", "disease" ]
[ 0, 0, 0, 2, 2 ]
NCT02964039
17:23:chronic_disease
Experience of a stroke 6 months prior to participation
2
[ "Experience", "of", "a", "stroke", "6", "months", "prior", "to", "participation" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT03153969
12:32:chronic_disease
Teeth with periapical pathology
2
[ "Teeth", "with", "periapical", "pathology" ]
[ 0, 0, 2, 2 ]
NCT02105545
20:29:cancer
Any patient with a malignant diagnosis at the time of diagnosis or relapse
2
[ "Any", "patient", "with", "a", "malignant", "diagnosis", "at", "the", "time", "of", "diagnosis", "or", "relapse" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02169739
33:64:chronic_disease
other prior cortical or retinal transient ischemic attack (TIA)
2
[ "other", "prior", "cortical", "or", "retinal", "transient", "ischemic", "attack", "(", "TIA", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT01459107
119:137:treatment,244:253:treatment,356:387:treatment
No co-existing medical condition which, in the opinion of the study team, could affect the immunomodulatory protocol, surgical procedure, or functional results (see Donor and Recipient Exclusion Criteria below. If the condition is amenable to treatment, the study team must agree that said condition should not significa...
2
[ "No", "co-existing", "medical", "condition", "which", ",", "in", "the", "opinion", "of", "the", "study", "team", ",", "could", "affect", "the", "immunomodulatory", "protocol", ",", "surgical", "procedure", ",", "or", "functional", "results", "(", "see", "Donor...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0...
NCT01220583
4:31:treatment,35:52:treatment,57:82:cancer,84:102:treatment,119:125:cancer
No prior systemic chemotherapy or radiation therapy for salivary gland malignancy (prior chemotherapy for a different cancer is allowable)
2
[ "No", "prior", "systemic", "chemotherapy", "or", "radiation", "therapy", "for", "salivary", "gland", "malignancy", "(", "prior", "chemotherapy", "for", "a", "different", "cancer", "is", "allowable", ")" ]
[ 0, 1, 1, 1, 0, 1, 1, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0 ]
NCT03029806
15:27:chronic_disease,29:37:chronic_disease,39:45:chronic_disease,47:70:chronic_disease,72:86:chronic_disease,88:94:cancer,96:111:chronic_disease,113:125:chronic_disease,130:146:treatment,
No history of hypertension, diabetes, stroke, coronary artery disease, kidney disease, cancer, thyroid disease, preeclampsia, or hospitalizations in 6 months
2
[ "No", "history", "of", "hypertension", ",", "diabetes", ",", "stroke", ",", "coronary", "artery", "disease", ",", "kidney", "disease", ",", "cancer", ",", "thyroid", "disease", ",", "preeclampsia", ",", "or", "hospitalizations", "in", "6", "months" ]
[ 0, 0, 0, 2, 0, 2, 0, 2, 0, 2, 2, 2, 0, 2, 2, 0, 3, 0, 2, 2, 0, 2, 0, 0, 1, 0, 0, 0 ]
NCT02978638
21:36:chronic_disease
Active or recurrent pressure ulcers, particularly in sacral, ischial or trochanteric areas
2
[ "Active", "or", "recurrent", "pressure", "ulcers", ",", "particularly", "in", "sacral", ",", "ischial", "or", "trochanteric", "areas" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02583893
22:32:cancer,,,104:120:cancer,133:147:cancer,152:169:cancer
Previously untreated non-M3 AML age >60 with no evidence of favorable karyotype defined by presence of t(8;21)(q22;q22) [AML1-ETO], inv16(p13;q22), or t(16;16)(p13;q22) [CBFβ;MYH11] by cytogenetics, FISH, or RT-PCR
2
[ "Previously", "untreated", "non-M3", "AML", "age", ">", "60", "with", "no", "evidence", "of", "favorable", "karyotype", "defined", "by", "presence", "of", "t", "(", "8", ";", "21", ")", "(", "q22", ";", "q22", ")", "[", "AML1-ETO", "]", ",", "inv16", ...
[ 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3 ]
NCT02013154
31:49:chronic_disease,82:90:chronic_disease,92:109:chronic_disease,114:123:chronic_disease,138:156:treatment
History of known or suspected autoimmune disease with the specific exceptions of vitiligo, atopic dermatitis, or psoriasis not requiring systemic treatment
2
[ "History", "of", "known", "or", "suspected", "autoimmune", "disease", "with", "the", "specific", "exceptions", "of", "vitiligo", ",", "atopic", "dermatitis", ",", "or", "psoriasis", "not", "requiring", "systemic", "treatment" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 2, 0, 0, 1, 1 ]
NCT02710396
1:12:chronic_disease,
Hepatitis C (e.g., HCV RNA [qualitative] is detected)
2
[ "Hepatitis", "C", "(", "e.g.", ",", "HCV", "RNA", "[", "qualitative", "]", "is", "detected", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02617589
24:27:cancer
Recurrent or secondary GBM
2
[ "Recurrent", "or", "secondary", "GBM" ]
[ 0, 0, 0, 3 ]
NCT03104699
1:14:treatment,24:98:treatment,107:116:treatment,118:128:treatment,133:190:treatment
Prior therapy with any antibody/drug targeting T-cell co-regulatory proteins (immune checkpoints) such as anti-PD-1, anti-PD-L1, or anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) antibodies
2
[ "Prior", "therapy", "with", "any", "antibody/drug", "targeting", "T-cell", "co-regulatory", "proteins", "(", "immune", "checkpoints", ")", "such", "as", "anti-PD-1", ",", "anti-PD-L1", ",", "or", "anti-cytotoxic", "T-lymphocyte", "antigen", "4", "(", "CTLA-4", ")"...
[ 1, 1, 0, 0, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1, 1, 1, 1, 1, 0, 0 ]
NCT02543983
87:99:chronic_disease,101:109:chronic_disease,133:144:treatment
Presence of medical illness likely to alter brain morphology and/or physiology (e.g., hypertension, diabetes) even if controlled by medications
2
[ "Presence", "of", "medical", "illness", "likely", "to", "alter", "brain", "morphology", "and/or", "physiology", "(", "e.g.", ",", "hypertension", ",", "diabetes", ")", "even", "if", "controlled", "by", "medications" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0, 0, 1 ]
NCT02780401
15:29:cancer,31:44:cancer,46:73:cancer
Patients with non-metastatic, node positive, HER2 negative breast cancer, confirmed by pathology report, who are in remission and defined as having no evidence of disease (NED)
2
[ "Patients", "with", "non-metastatic", ",", "node", "positive", ",", "HER2", "negative", "breast", "cancer", ",", "confirmed", "by", "pathology", "report", ",", "who", "are", "in", "remission", "and", "defined", "as", "having", "no", "evidence", "of", "disease"...
[ 0, 0, 3, 0, 3, 3, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00630565
15:40:chronic_disease,75:82:cancer,84:92:cancer,127:142:treatment
Patients with cytogenetic abnormalities suggesting an improved prognosis [t(8:21), t(15;17) and inv(16)] will be eligible for transplantation in first remission
2
[ "Patients", "with", "cytogenetic", "abnormalities", "suggesting", "an", "improved", "prognosis", "[", "t", "(", "8:21", ")", ",", "t", "(", "15", ";", "17", ")", "and", "inv", "(", "16", ")", "]", "will", "be", "eligible", "for", "transplantation", "in",...
[ 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 1, 3, 3, 3 ]
NCT02339922
51:73:treatment,
Participation in other clinical trials with other investigational agents not included in this trial, within 21 days of the start of this trial and throughout the duration of this trial
2
[ "Participation", "in", "other", "clinical", "trials", "with", "other", "investigational", "agents", "not", "included", "in", "this", "trial", ",", "within", "21", "days", "of", "the", "start", "of", "this", "trial", "and", "throughout", "the", "duration", "of"...
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02369653
1:33:chronic_disease
Uncontrolled severe hypertension at enrollment
2
[ "Uncontrolled", "severe", "hypertension", "at", "enrollment" ]
[ 2, 2, 2, 0, 0 ]
NCT01600131
56:62:chronic_disease
All caregivers of Veterans with a primary diagnosis of stroke
2
[ "All", "caregivers", "of", "Veterans", "with", "a", "primary", "diagnosis", "of", "stroke" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT02053909
12:35:chronic_disease
History of intracranial hemorrhage
2
[ "History", "of", "intracranial", "hemorrhage" ]
[ 0, 0, 2, 2 ]
NCT00001337
1:31:cancer
mediastinal gray zone lymphoma
2
[ "mediastinal", "gray", "zone", "lymphoma" ]
[ 3, 3, 3, 3 ]
NCT01943851
,,,,127:138:treatment
In addition, male subjects whose partners are or become pregnant must continue to use condoms for 7 days after stopping study medications
2
[ "In", "addition", ",", "male", "subjects", "whose", "partners", "are", "or", "become", "pregnant", "must", "continue", "to", "use", "condoms", "for", "7", "days", "after", "stopping", "study", "medications" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03043807
1:16:treatment,
hormone therapy was recently initiated (<90 days duration))
2
[ "hormone", "therapy", "was", "recently", "initiated", "(", "<", "90", "days", "duration", ")", ")" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02468024
15:46:cancer
Patients with non-peripheral (central) tumors are NOT eligible
2
[ "Patients", "with", "non-peripheral", "(", "central", ")", "tumors", "are", "NOT", "eligible" ]
[ 0, 0, 3, 3, 3, 0, 0, 0, 0, 0 ]
NCT02356653
1:10:cancer
Lymphomas
2
[ "Lymphomas" ]
[ 3 ]
NCT02675959
56:75:chronic_disease
Patients must demonstrate one or more of the following Sickle Cell Disease Complications (or patients in Cohort 2 can meet other high risk criteria instead)
2
[ "Patients", "must", "demonstrate", "one", "or", "more", "of", "the", "following", "Sickle", "Cell", "Disease", "Complications", "(", "or", "patients", "in", "Cohort", "2", "can", "meet", "other", "high", "risk", "criteria", "instead", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01894061
16:27:treatment
The effects of bevacizumab on developing fetus or nursing infant are not known
2
[ "The", "effects", "of", "bevacizumab", "on", "developing", "fetus", "or", "nursing", "infant", "are", "not", "known" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01799538
47:68:cancer,70:87:cancer,89:109:chronic_disease
evidence of lung and other organ involvement (renal angiomyolipomas, chylous effusions, lymphangioleiomyomas)
2
[ "evidence", "of", "lung", "and", "other", "organ", "involvement", "(", "renal", "angiomyolipomas", ",", "chylous", "effusions", ",", "lymphangioleiomyomas", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 0, 2, 0 ]
NCT02495389
1:19:chronic_disease
Neurologic disease known to affect the lower urinary tract
2
[ "Neurologic", "disease", "known", "to", "affect", "the", "lower", "urinary", "tract" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02452203
1:4:treatment,34:51:treatment,53:97:treatment,99:120:treatment,122:132:treatment,134:171:treatment,173:184:treatment,186:209:treatment,211:240:treatment,242:252:treatment,254:285:treatment,290:323:treatment,399:410:treatment,,,545:563:treatment,
MRI contraindications including: cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/ wires, or neuro/bio-stimulators (TENS uni...
2
[ "MRI", "contraindications", "including", ":", "cardiac", "pacemaker", ",", "metal", "fragments", "in", "eyes/skin/body", "(", "shrapnel", ")", ",", "aortic/aneurysm", "clips", ",", "prosthesis", ",", "by-pass", "surgery/coronary", "artery", "clips", ",", "hearing", ...
[ 1, 0, 0, 0, 1, 1, 0, 1, 1, 1, 1, 1, 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 1, 1, 0, 1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT02148796
44:80:chronic_disease,95:105:treatment,110:132:treatment
Participants may not have a history of any life-threatening respiratory illness that required intubation and mechanical ventilation
2
[ "Participants", "may", "not", "have", "a", "history", "of", "any", "life-threatening", "respiratory", "illness", "that", "required", "intubation", "and", "mechanical", "ventilation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 1, 0, 1, 1 ]
NCT02548104
1:19:chronic_disease
Bleeding diathesis
2
[ "Bleeding", "diathesis" ]
[ 2, 2 ]
NCT01783535
31:49:chronic_disease
Participants must not have an invasive infection at time of protocol entry
2
[ "Participants", "must", "not", "have", "an", "invasive", "infection", "at", "time", "of", "protocol", "entry" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02514083
1:25:chronic_disease,27:44:chronic_disease,48:72:chronic_disease,197:206:treatment,211:222:treatment
Life-threatening illness, medical condition or organ system dysfunction which, in the investigator s opinion, could compromise the subject s safety, interfere with the absorption or metabolism of ibrutinib and fludarabine, or put the study outcomes at undue risk
2
[ "Life-threatening", "illness", ",", "medical", "condition", "or", "organ", "system", "dysfunction", "which", ",", "in", "the", "investigator", "s", "opinion", ",", "could", "compromise", "the", "subject", "s", "safety", ",", "interfere", "with", "the", "absorpti...
[ 2, 2, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02682407
19:35:treatment
Have a history of renal transplant
2
[ "Have", "a", "history", "of", "renal", "transplant" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT02088554
15:55:chronic_disease,,
Patient has a non-cardiac major or progressive disease, with a life expectancy of less than 2 years
2
[ "Patient", "has", "a", "non-cardiac", "major", "or", "progressive", "disease", ",", "with", "a", "life", "expectancy", "of", "less", "than", "2", "years" ]
[ 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02436070
1:20:chronic_disease
Sickle Cell disease
2
[ "Sickle", "Cell", "disease" ]
[ 2, 2, 2 ]
NCT02213913
1:16:cancer,22:62:treatment,36:56:treatment,209:213:cancer,216:219:cancer,245:257:treatment
B-cell lymphoma with comprehensive immunohistochemistry (IHC) panel establishing lineage (CD20, CD3) and cell of origin (CD10, BCL6 and MUM1) in addition to proliferative/prognostic markers (Ki-67, C-myc and BCL2). DHL will be identified using cytogenetics and/or immunohistochemistry
2
[ "B-cell", "lymphoma", "with", "comprehensive", "immunohistochemistry", "(", "IHC", ")", "panel", "establishing", "lineage", "(", "CD20", ",", "CD3", ")", "and", "cell", "of", "origin", "(", "CD10", ",", "BCL6", "and", "MUM1", ")", "in", "addition", "to", "...
[ 3, 3, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 0, 0, 0, 0, 1, 0, 0 ]
NCT02595372
1:11:treatment,13:21:treatment,23:30:treatment
Omeprazole (Prilosec, Zegerid)
2
[ "Omeprazole", "(", "Prilosec", ",", "Zegerid", ")" ]
[ 1, 0, 1, 0, 1, 0 ]
NCT03045341
,,,29:36:chronic_disease
BMI 27-30 with a controlled obesity-related co-morbidity
2
[ "BMI", "27-30", "with", "a", "controlled", "obesity-related", "co-morbidity" ]
[ 0, 0, 0, 0, 0, 2, 0 ]
NCT02418195
1:12:chronic_disease
Post-partum state
2
[ "Post-partum", "state" ]
[ 2, 0 ]
NCT02584309
1:23:chronic_disease,,
Systolic heart failure defined as left ventricular ejection fraction ≤ 45%
2
[ "Systolic", "heart", "failure", "defined", "as", "left", "ventricular", "ejection", "fraction", "≤", "45", "%" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02741180
1:24:chronic_disease
Hemodynamic instability
2
[ "Hemodynamic", "instability" ]
[ 2, 2 ]
NCT02393794
1:28:chronic_disease
Congenital long QT syndrome
2
[ "Congenital", "long", "QT", "syndrome" ]
[ 2, 2, 2, 2 ]
NCT01614990
1:8:chronic_disease,,
Obesity (body weight >140 Kg)
2
[ "Obesity", "(", "body", "weight", ">", "140", "Kg", ")" ]
[ 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT01943851
8:22:treatment,30:38:treatment,40:47:treatment,,
Use of anticoagulants (e.g., warfarin, heparin) at therapeutic levels within 7 days prior to the first dose of GSK525762
2
[ "Use", "of", "anticoagulants", "(", "e.g.", ",", "warfarin", ",", "heparin", ")", "at", "therapeutic", "levels", "within", "7", "days", "prior", "to", "the", "first", "dose", "of", "GSK525762" ]
[ 0, 0, 1, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02377089
27:31:chronic_disease,,
with significant residual PTSD symptoms as evidenced by a CAPS score >50
2
[ "with", "significant", "residual", "PTSD", "symptoms", "as", "evidenced", "by", "a", "CAPS", "score", ">", "50" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02404155
63:76:chronic_disease
treatment would likely alter the presentation or treatment of schizophrenia or significantly increase the risks associated with the proposed protocol
2
[ "treatment", "would", "likely", "alter", "the", "presentation", "or", "treatment", "of", "schizophrenia", "or", "significantly", "increase", "the", "risks", "associated", "with", "the", "proposed", "protocol" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02343549
13:38:chronic_disease
Significant liver function impairment
2
[ "Significant", "liver", "function", "impairment" ]
[ 0, 2, 2, 2 ]
NCT01568177
1:12:chronic_disease
myocarditis
2
[ "myocarditis" ]
[ 2 ]
NCT02373644
1:3:chronic_disease
RA
2
[ "RA" ]
[ 2 ]
NCT03070535
27:33:cancer
Remote history of treated cancer is ok, as long as current cognition and digestion are not affected
2
[ "Remote", "history", "of", "treated", "cancer", "is", "ok", ",", "as", "long", "as", "current", "cognition", "and", "digestion", "are", "not", "affected" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01928589
38:75:treatment,77:85:treatment,87:125:treatment,127:161:treatment,176:215:treatment,255:267:treatment,269:285:treatment,289:300:treatment,460:486:treatment,,,546:561:treatment,,,,,721:737:treatment,,839:856:treatment
Recommended regimens are as follows: Cyclophosphamide and Doxorubicin (AC); Taxotere, Doxorubicin and Cyclophosphamide (TAC); Taxotere and Cyclophosphamide (TC); or Taxotere, Carboplatin and Trastuzamab (TCH) prior to registration. The use of additional chemotherapy, hormonal therapy or Trastuzumab after the initial re...
2
[ "Recommended", "regimens", "are", "as", "follows", ":", "Cyclophosphamide", "and", "Doxorubicin", "(", "AC", ")", ";", "Taxotere", ",", "Doxorubicin", "and", "Cyclophosphamide", "(", "TAC", ")", ";", "Taxotere", "and", "Cyclophosphamide", "(", "TC", ")", ";", ...
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
NCT02397889
,81:85:chronic_disease
Participants must fulfill DSM-5 criteria for current civilian or combat-related PTSD
2
[ "Participants", "must", "fulfill", "DSM-5", "criteria", "for", "current", "civilian", "or", "combat-related", "PTSD" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT01925131
111:118:treatment,,,210:222:treatment,224:246:treatment,250:274:treatment
in addition to routine contraceptive methods, effective contraception also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation
2
[ "in", "addition", "to", "routine", "contraceptive", "methods", ",", "effective", "contraception", "also", "includes", "heterosexual", "celibacy", "and", "surgery", "intended", "to", "prevent", "pregnancy", "(", "or", "with", "a", "side-effect", "of", "pregnancy", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0, 0, 0 ]
NCT02452008
21:28:chronic_disease
Have a history of a seizure
2
[ "Have", "a", "history", "of", "a", "seizure" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02576301
1:29:cancer
Acute promyelocytic leukemia
2
[ "Acute", "promyelocytic", "leukemia" ]
[ 3, 3, 3 ]
NCT01464034
22:42:cancer
Current diagnosis of plasma cell leukemia
2
[ "Current", "diagnosis", "of", "plasma", "cell", "leukemia" ]
[ 0, 0, 0, 3, 3, 3 ]
NCT02466685
1:16:treatment
antidepressants
2
[ "antidepressants" ]
[ 1 ]
NCT01701986
21:57:chronic_disease
Patient with active central nervous system (CNS) disease
2
[ "Patient", "with", "active", "central", "nervous", "system", "(", "CNS", ")", "disease" ]
[ 0, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02121184
21:40:allergy_name
Contraindication to neuraxial analgesia
2
[ "Contraindication", "to", "neuraxial", "analgesia" ]
[ 0, 0, 4, 4 ]
NCT02033941
1:21:chronic_disease,32:51:chronic_disease,53:69:chronic_disease,74:98:chronic_disease,
Major mental illness including psychotic disorders, bipolar disorder, or major depressive episode that is not in remission for less than 12 months
2
[ "Major", "mental", "illness", "including", "psychotic", "disorders", ",", "bipolar", "disorder", ",", "or", "major", "depressive", "episode", "that", "is", "not", "in", "remission", "for", "less", "than", "12", "months" ]
[ 2, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02508311
1:16:chronic_disease
Hyperthyroidism
2
[ "Hyperthyroidism" ]
[ 2 ]
NCT02365766
5:14:treatment,,,
The cisplatin dose will be split over two days for values between 50-59 mL/min
2
[ "The", "cisplatin", "dose", "will", "be", "split", "over", "two", "days", "for", "values", "between", "50-59", "mL/min" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02048722
,9:24:treatment
up to 4 prior therapies are allowed
2
[ "up", "to", "4", "prior", "therapies", "are", "allowed" ]
[ 0, 0, 0, 1, 1, 0, 0 ]
NCT02531711
12:25:allergy_name
History of specific food allergies that would prevent adherence to study diet
2
[ "History", "of", "specific", "food", "allergies", "that", "would", "prevent", "adherence", "to", "study", "diet" ]
[ 0, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02234934
9:22:treatment,,
Resting O2 saturation by pulse oximetry < 90% on room air
2
[ "Resting", "O2", "saturation", "by", "pulse", "oximetry", "<", "90", "%", "on", "room", "air" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01994382
,,70:73:cancer,74:77:cancer,81:108:cancer,110:115:cancer,117:119:cancer,121:124:cancer,126:129:cancer,131:157:cancer
Specific Patient at least 18yrs of age with histologically confirmed CLL/SLL or B-cell Non-Hodgkin lymphoma (DLBCL, FL, MCL, MZL, lymphoplasmacytic lymphoma)
2
[ "Specific", "Patient", "at", "least", "18yrs", "of", "age", "with", "histologically", "confirmed", "CLL/SLL", "or", "B-cell", "Non-Hodgkin", "lymphoma", "(", "DLBCL", ",", "FL", ",", "MCL", ",", "MZL", ",", "lymphoplasmacytic", "lymphoma", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 3, 3, 0, 3, 0, 3, 0, 3, 0, 3, 0, 3, 3, 0 ]
NCT02570854
1:18:treatment,
Blood transfusion administered within 4 weeks prior to baseline
2
[ "Blood", "transfusion", "administered", "within", "4", "weeks", "prior", "to", "baseline" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02570256
1:18:chronic_disease
bilateral paresis
2
[ "bilateral", "paresis" ]
[ 2, 2 ]
NCT02811679
21:34:chronic_disease
Subjects with known HIV infection
2
[ "Subjects", "with", "known", "HIV", "infection" ]
[ 0, 0, 0, 2, 2 ]
NCT01367444
1:16:treatment,51:68:treatment,70:82:treatment
Laboratory test abnormalities or abnormalities in electrocardiogram, chest X-rays that in the opinion of the Principal Investigator would make the patient unsuitable for participation in the study
2
[ "Laboratory", "test", "abnormalities", "or", "abnormalities", "in", "electrocardiogram", ",", "chest", "X-rays", "that", "in", "the", "opinion", "of", "the", "Principal", "Investigator", "would", "make", "the", "patient", "unsuitable", "for", "participation", "in", ...
[ 1, 1, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01659541
1:10:chronic_disease,12:32:chronic_disease,37:51:chronic_disease
Scoliosis, chest wall deformity, or marked obesity
2
[ "Scoliosis", ",", "chest", "wall", "deformity", ",", "or", "marked", "obesity" ]
[ 2, 0, 2, 2, 2, 0, 0, 2, 2 ]
NCT02876302
43:61:cancer
Extensive nodal involvement is defined as metastatic disease involving any nodal region outside of the involved breast
2
[ "Extensive", "nodal", "involvement", "is", "defined", "as", "metastatic", "disease", "involving", "any", "nodal", "region", "outside", "of", "the", "involved", "breast" ]
[ 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01624090
63:75:cancer,80:101:cancer,103:119:cancer,121:137:cancer,139:170:cancer,174:193:cancer
Patients with measurable inoperable, histologically confirmed primary lung and esophageal carcinomas, thymic neoplasms, germ cell tumors, malignant pleural mesotheliomas or chest wall sarcomas
2
[ "Patients", "with", "measurable", "inoperable", ",", "histologically", "confirmed", "primary", "lung", "and", "esophageal", "carcinomas", ",", "thymic", "neoplasms", ",", "germ", "cell", "tumors", ",", "malignant", "pleural", "mesotheliomas", "or", "chest", "wall", ...
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 3, 3, 0, 3, 3, 0, 3, 3, 3, 0, 3, 3, 3, 0, 3, 3, 3 ]
NCT02315196
13:29:chronic_disease,37:52:chronic_disease,54:71:chronic_disease
Significant vascular disease (e.g., aortic aneurysm, aortic dissection)
2
[ "Significant", "vascular", "disease", "(", "e.g.", ",", "aortic", "aneurysm", ",", "aortic", "dissection", ")" ]
[ 0, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT03063892
12:35:chronic_disease
History of intracranial hemorrhage
2
[ "History", "of", "intracranial", "hemorrhage" ]
[ 0, 0, 2, 2 ]
NCT01627301
63:67:chronic_disease
Prehypertensive and Normotensive OEF/OIF/OND veterans without PTSD (controls)
2
[ "Prehypertensive", "and", "Normotensive", "OEF/OIF/OND", "veterans", "without", "PTSD", "(", "controls", ")" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0 ]
NCT02973425
60:76:treatment,,
The Food and Drug Administration (FDA) advises caution for nicotine lozenge use among women who are pregnant
2
[ "The", "Food", "and", "Drug", "Administration", "(", "FDA", ")", "advises", "caution", "for", "nicotine", "lozenge", "use", "among", "women", "who", "are", "pregnant" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT03059355
1:24:cancer
squamous cell carcinoma
2
[ "squamous", "cell", "carcinoma" ]
[ 3, 3, 3 ]
NCT02121158
,,,23:36:chronic_disease
NYHA Class II and III heart failure
2
[ "NYHA", "Class", "II", "and", "III", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT03049189
9:28:treatment
Planned alternative therapy (for the period of study participation)
2
[ "Planned", "alternative", "therapy", "(", "for", "the", "period", "of", "study", "participation", ")" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02857270
83:89:treatment
Currently using concomitant medications that are strong inhibitors or inducers of CYP3A4
2
[ "Currently", "using", "concomitant", "medications", "that", "are", "strong", "inhibitors", "or", "inducers", "of", "CYP3A4" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02484404
,19:60:treatment
with at least one prior line of platinum-based chemotherapy are eligible
2
[ "with", "at", "least", "one", "prior", "line", "of", "platinum-based", "chemotherapy", "are", "eligible" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0 ]
NCT01947140
1:17:cancer
Multiple Myeloma patients specified in the protocol
2
[ "Multiple", "Myeloma", "patients", "specified", "in", "the", "protocol" ]
[ 3, 3, 0, 0, 0, 0, 0 ]
NCT02253316
1:17:cancer
multiple myeloma
2
[ "multiple", "myeloma" ]
[ 3, 3 ]
NCT02234193
22:53:treatment
scheduled to undergo elective abdominoplasty surgery at MGH
2
[ "scheduled", "to", "undergo", "elective", "abdominoplasty", "surgery", "at", "MGH" ]
[ 0, 0, 0, 1, 1, 1, 0, 0 ]
NCT02128802
21:29:treatment
Non-compliance with dialysis regimen
2
[ "Non-compliance", "with", "dialysis", "regimen" ]
[ 0, 0, 1, 0 ]